Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.4956
-0.1437 (-22.48%)
Nov 2, 2026, 12:14 PM EST - Market open
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $21.56 million as of November 2, 2026. It is the 34,378th most valuable company in the world and the 5,009th biggest in the United States. Its market cap has decreased by 75.97% in one year.
Market Cap
21.56M
Enterprise Value
21.41M
1-Year Change
-75.97%
Global Rank
Country Rank
#5,009 United States
Category
ChartMarket Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $21.56M, an increase of 1,112.73%. That is a compound annual growth rate of 85.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 21.56M | -63.41% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aligos Therapeutics | 29.97M |
| Aardvark Therapeutics | 29.76M |
| ProMIS Neurosciences | 29.68M |
| Metagenomi Therapeutics | 29.48M |
| NextCure | 28.88M |
| TransCode Therapeutics | 27.60M |
| BriaCell Therapeutics | 26.81M |
| BeyondSpring | 26.47M |